Back
Genmab AS 10K Form
Sell
22
GMAB
Genmab AS
Last Price:
26.19
Seasonality Move:
6.18%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive GMAB News And Ratings
See the #1 stock for the next 7 days that we like better than GMAB
GMAB Financial Statistics
Sales & Book Value
| Annual Sales: | $2.39B |
|---|---|
| Cash Flow: | $212.55M |
| Price / Cash Flow: | 18.45 |
| Annual Sales: | $7.00 |
| Price / Book: | 3.77 |
Profitability
| EPS (TTM): | 1.21870 |
|---|---|
| Net Income (TTM): | $799.51M |
| Gross Margin: | $2.36B |
| Return on Equity: | 17.81% |
| Return on Assets: | 15.53% |
Genmab AS Earnings Forecast
Key Genmab AS Financial Ratios
- The Gross Profit Margin over the past 17 years for GMAB is 98.63%.
- The Selling, General & Administrative Expenses for GMAB have been equal to 20.01% of Gross Profit Margin.
- The Research & Development expenses have been 46.32% of Revenue.
- The Interest Expense is 0.62% of Operating Income.
- The Net Earning history of GMAB is 26.42% of Total Revenues.
- Per Share Earnings over the last 22 years have been positive in 15 years.
Genmab AS Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | GMAB |
| Website: | genmab.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 5.03 |
| Quick Ratio: | 5.02 |
Price-to-Earnings
| Trailing P/E Ratio: | 27.57 |
|---|---|
| Forward P/E Ratio: | 16.4 |